Results 201 to 210 of about 45,078 (268)

Cholera vaccine deployed to control African outbreak [PDF]

, 2012
Gozde Zorlu
openalex   +1 more source

Oral cholera vaccine given marketing authorisation in European Union

, 2004
Collective Editorial team
openalex   +1 more source

Effectiveness of the Euvichol® oral cholera vaccine at 2 years: A case-control and bias-indicator study in Haiti. [PDF]

Int J Infect Dis
Matias WR, Guillaume Y, Cene Augustin G, Vissieres K, Ternier R, Slater DM, Harris JB, Franke MF, Ivers LC.   +8 more
europepmc   +1 more source

Isolation and identification of the causative agent of fowl cholera in Iraq and preparation of vaccines against the disease 1- Isolation of the causative agent of fowl cholera and study of it’s properties.

, 2005
Hatem M .Mhanam‎
openalex   +2 more sources

Knowledge, attitude and practice on cholera and cholera vaccine among low socio-economic group of people in urban Dhaka, Bangladesh [PDF]

, 2012
Tasnuva Wahed, Md. Jasim Uddin, Iqbal Ansary Khan, Sheikh Shah Tanvir Kaukab, Nirod Chandra Saha, Firdausi Qadri   +5 more
openalex   +1 more source

MucoRice-CTB line 19A, a new marker-free transgenic rice-based cholera vaccine produced in an LED-based hydroponic system. [PDF]

Front Plant Sci
Yuki Y, Kurokawa S, Sugiura K, Kashima K, Maruyama S, Yamanoue T, Honma A, Mejima M, Takeyama N, Kuroda M, Kozuka-Hata H, Oyama M, Masumura T, Nakahashi-Ouchida R, Fujihashi K, Hiraizumi T, Goto E, Kiyono H.   +17 more
europepmc   +1 more source

Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: a matched case-control study. [PDF]

Lancet Infect Dis
Malembaka EB, Bugeme PM, Hutchins C, Xu H, Hulse JD, Demby MN, Gallandat K, Saidi JM, Rumedeka BB, Itongwa M, Tshiwedi-Tsilabia E, Kitoga F, Bodisa-Matamu T, Kavunga-Membo H, Bengehya J, Kulondwa JC, Debes AK, Taty N, Lee EC, Lunguya O, Lessler J, Leung DT, Cumming O, Okitayemba PW, Mukadi-Bamuleka D, Knee J, Azman AS.   +26 more
europepmc   +1 more source

Acid-detoxified Inaba lipopolysaccharide (pmLPS) is a superior cholera conjugate vaccine immunogen than hydrazine-detoxified lipopolysaccharide and induces vibriocidal and protective antibodies [PDF]

, 2013
Cyrille Grandjean, Terri K. Wade, David Ropartz, Logan Ernst, William F. Wade   +4 more
openalex   +1 more source

COVID-19 Vaccine Hesitancy and Associated Oral Cholera Vaccine Hesitancy in a Cholera-Endemic Country: A Community-Based Cross-Sectional Study in the Democratic Republic of Congo. [PDF]

Vaccines (Basel)
Nyalundja AD, Bugeme PM, Ntaboba AB, Hatu'm VU, Ashuza GS, Tamuzi JL, Ndwandwe D, Iwu-Jaja C, Wiysonge CS, Katoto PDMC.   +9 more
europepmc   +1 more source

CAUSAL INFERENCE FROM OBSERVATIONAL STUDIES WITH CLUSTERED INTERFERENCE, WITH APPLICATION TO A CHOLERA VACCINE STUDY. [PDF]

Ann Appl Stat, 2020
Barkley BG, Hudgens MG, Clemens JD, Ali M, Emch ME.   +4 more
europepmc   +1 more source